Stocks and Investing
Stocks and Investing
Fri, September 6, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, September 5, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, September 4, 2019
[ 12:00 AM ] - United States, WOPRAI
Esther Rajavelu Maintained (ALNY) at Hold with Increased Target to $96 on, Sep 4th, 2019
Esther Rajavelu of UBS, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $95 to $96 on, Sep 4th, 2019.
Esther has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Esther's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Esther
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $145 on, Tuesday, September 3rd, 2019
- David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $124 on, Wednesday, August 7th, 2019
Contributing Sources